Partners

Photonics is an industry that has aroused Merck's curiosity for more than 30 years

Merck is accelerating development and production, and bringing resources and expertise to help identify effective and...

Innovation present in Oryzon's programs in the field of epigenetics acknowledged. The company currently has 2 compounds...

This article will focus on the Systematic Scientific Literature Search and Review as part of the Clinical Evaluation...

This collaboration responds to the high quality of the research and scientific talent of the Hospital Nacional de...

Mirum expands potential opportunities across rare disease pipeline and Vivet will lead pre-clinical development of its...

Biotech company OWL Metabolomics develops non-invasive, early diagnosis products for obesity-related diseases

Goal is to explore effects of LSD1 inhibition on animal models of autism in Shank3 deficient mice models

In 2020, biologist Gema Malet Engra joined the biotechnology company Laminar Pharmaceuticals after a successful 15-year...

PORTICO is a Phase IIb clinical trial with vafidemstat in Borderline Personality Disorder recruiting patients in Europe...